BioStem Technologies, Inc. (OTCMKTS:BSEM - Get Free Report)'s stock price fell 7.8% during mid-day trading on Monday . The stock traded as low as $6.06 and last traded at $6.18. 51,184 shares traded hands during trading, a decline of 50% from the average session volume of 101,625 shares. The stock had previously closed at $6.70.
BioStem Technologies Price Performance
The firm's fifty day moving average price is $9.16 and its 200-day moving average price is $10.98. The company has a market capitalization of $83.42 million, a price-to-earnings ratio of 4.37 and a beta of -0.32.
BioStem Technologies Company Profile
(
Get Free Report)
BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.
Featured Articles
Before you consider BioStem Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BioStem Technologies wasn't on the list.
While BioStem Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
